.mCSB_scrollTools .mCSB_buttonDown,.mCSB_scrollTools .mCSB_buttonLeft,.mCSB_scrollTools .mCSB_buttonRight,.mCSB_scrollTools .mCSB_buttonUp{--wpr-bg-c95d6f46-a0e7-49fd-ab5e-1bb581b7f2e4: url('https://neomondo.org.br/wp-content/plugins/8degree-fly-menu-lite/css/mCSB_buttons.png');}.penci-owl-carousel .owl-video-play-icon{--wpr-bg-16b0c12a-e57a-4a9c-ae0b-46a588fb868c: url('https://neomondo.org.br/wp-content/themes/soledad/owl.video.play.png');}.featured-area.featured-video{--wpr-bg-8c0812a1-231d-4a94-99cc-a9d1883f88c1: url('https://neomondo.org.br/wp-content/themes/soledad/images/loading.gif');}.penci-image-holder{--wpr-bg-6dbc31c0-50ae-4bfa-a0b2-ae56bc1d85a3: url('https://neomondo.org.br/wp-content/themes/soledad/images/no-image.jpg');}.penci-magazine-slider.penci-loading{--wpr-bg-668bd940-2405-4dbf-aed3-62ae4f12ef37: url('https://neomondo.org.br/wp-content/themes/soledad/images/loading.gif');}#searchform input.search-input{--wpr-bg-e828d71e-1a5f-497d-9315-58e8c8213415: url('https://neomondo.org.br/wp-content/themes/soledad/images/searchsubmit.png');}.dark-layout-enabled .featured-area.featured-video{--wpr-bg-c9690e62-aa5b-45a2-90be-323da28f7c68: url('https://neomondo.org.br/wp-content/themes/soledad/images/loading2.gif');}body.penci-body-boxed{--wpr-bg-7c2ce797-8c04-4587-98d5-9c4ded11499c: url('https://soledad.pencidesign.com/soledad-magazine/wp-content/uploads/sites/7/2017/06/notebook.png');}#floating-nextprev .floating-nextprev-arrow-left{--wpr-bg-50d1ae8b-0b9e-476b-84f6-e0b5f371425b: url('https://neomondo.org.br/../../images/frontend/arrow-left.png');}#floating-nextprev .floating-nextprev-arrow-right{--wpr-bg-a61d76d3-83de-428a-9991-8945d4f403d9: url('https://neomondo.org.br/../../images/frontend/arrow-right.png');}

Tag:

#médicossemfronteiras

Ciência e Tecnologia Destaques Diversidade e Inclusão Política Saúde Segurança Sustentabilidade
Por que o Brasil não tem os novos remédios recomendados para a Covid?

Por Neo Mondo 17 de março de 2022

FOTO: NATIONAL CANCER INSTITUTE / UNSPLASH Por – Pedro Villardi* e Felipe Carvalho* /…